HIV-associated pneumonia in the material is typically treated with which drug for Pneumocystis jirovecii pneumonia?

HIV-associated pneumonia in the material is typically treated with which drug for Pneumocystis jirovecii pneumonia?

• A. BACTRIM
• B. Azithromycin
• C. Ceftriaxone
• D. Vancomycin

Answer: (A)

First-line therapy for Pneumocystis jirovecii pneumonia in HIV is trimethoprim-sulfamethoxazole (TMP-SMX), commonly known as Bactrim. This combination effectively inhibits folate synthesis in Pneumocystis, halting its growth in the lungs and restoring oxygenation as the infection clears. It’s used for both mild and more severe PCP, with adjunctive corticosteroids recommended when there is significant hypoxemia to reduce lung inflammation and improve outcomes. The other options don’t target Pneumocystis: azithromycin is for certain bacterial infections, ceftriaxone and vancomycin treat bacterial pathogens and do not work against PCP. Hence, TMP-SMX is the best choice.

First-line therapy for Pneumocystis jirovecii pneumonia in HIV is trimethoprim-sulfamethoxazole (TMP-SMX), commonly known as Bactrim. This combination effectively inhibits folate synthesis in Pneumocystis, halting its growth in the lungs and restoring oxygenation as the infection clears. It’s used for both mild and more severe PCP, with adjunctive corticosteroids recommended when there is significant hypoxemia to reduce lung inflammation and improve outcomes. The other options don’t target Pneumocystis: azithromycin is for certain bacterial infections, ceftriaxone and vancomycin treat bacterial pathogens and do not work against PCP. Hence, TMP-SMX is the best choice.